-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HusM8u58nw4wiL7p0A54whj0ypbjyAjgWSnRIuikY8xLxZBWdySLqGUhZAVGR+2n 9FzLVxH24WzmSFroQ7IWHQ== 0001193125-08-076621.txt : 20080408 0001193125-08-076621.hdr.sgml : 20080408 20080407215014 ACCESSION NUMBER: 0001193125-08-076621 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20080407 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080408 DATE AS OF CHANGE: 20080407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CRC Health CORP CENTRAL INDEX KEY: 0001360474 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 731650429 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-135172 FILM NUMBER: 08744161 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BOULEVARD, SUITE 600 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 877-272-8668 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BOULEVARD, SUITE 600 CITY: CUPERTINO STATE: CA ZIP: 95014 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

April 7, 2008

Date of report (Date of earliest event reported)

 

 

CRC HEALTH CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   333-135172   73-1650429

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

20400 Stevens Creek Boulevard, Suite 600, Cupertino, California    95014
(Address of Principal Executive Offices)    (Zip code)

(877) 272-8668

(Registrant’s Telephone Number, including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


INFORMATION TO BE INCLUDED IN REPORT

 

Item 2.02 Results of Operations and Financial Condition

On April 7, 2008, CRC Health Corporation (“the Company”) reported operating results for the fourth quarter and twelve months ended December 31, 2007. A copy of the Company’s press release is furnished herewith as Exhibit 99.1.

The information included in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, except as shall be expressly set forth by specific reference in any such filing.

 

Item 9.01 Financial Statements and Exhibits

 

  (d) Exhibits

 

99.1

   Press Release dated April 7, 2008


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 7, 2008

 

CRC HEALTH CORPORATION
By:   /s/ KEVIN HOGGE
Name:   Kevin Hogge
Title:   Chief Financial Officer
  (Principal Financial Officer and Principal Accounting Officer)
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

NEWS RELEASE

FOR IMMEDIATE RELEASE: April 7, 2008

CRC Health Reports Operating Results

for the Quarter & Year Ended December 31, 2007

CUPERTINO, CA, April 7, 2008 – CRC Health Corporation (“CRC” or the “Company”), a leading provider of substance abuse treatment and youth treatment services through its wholly owned consolidated subsidiaries, announced its results for the fourth quarter and year ended December 31, 2007, reflecting contributions from the acquisition of Aspen Education Group, Inc. (“Aspen”) and other acquisitions in 2006 and 2007, and continued organic growth. In the year ended December 31, 2007, CRC completed four acquisitions and paid total cash consideration of approximately $32.9 million, including acquisition related expenses. The acquisitions are intended to provide expansion of its recovery, youth, and healthy living services into new geographic regions in the United States.

Bain Capital Partners’ acquisition of CRC

On February 6, 2006, investment funds managed by Bain Capital Partners, LLC (“Bain”) completed the acquisition of CRC for approximately $723.0 million. As part of the acquisition, certain members of the CRC management team partnered with Bain by retaining an equity stake in CRC. The acquisition resulted in several large merger-related expenses during the year ended December 31, 2006. CRC’s pro forma results excluding these non-recurring items can be derived from the reconciliation of non-GAAP “EBITDA from continuing operations” to non-GAAP “Adjusted Pro Forma EBITDA,” presented below. CRC refers to the February 6, 2006 Bain acquisition and the related mergers and related financings as the “Transactions.”

The date of the Bain acquisition was February 6, 2006 but for accounting purposes and to coincide with its normal financial closing, CRC has utilized February 1, 2006 as the effective date of the Bain acquisition. As a result, CRC has reported operating results and financial position for all periods presented prior to February 1, 2006 as those of the Predecessor Company and for all periods from and subsequent to February 1, 2006 as those of the Successor Company due to the resulting change in the basis of accounting. CRC’s operating results for the year ended December 31, 2006 are presented as the mathematical addition of the Predecessor Company’s operating results for the one month ended

 

1


January 31, 2006 to the Successor Company’s operating results for the eleven months ended December 31, 2006. This approach is not consistent with accounting principles generally accepted in the United States of America (“GAAP”) and may yield results that are not strictly comparable on a period-to-period basis primarily due to the impact of purchase accounting entries recorded as a result of the Transactions. However, CRC’s management believes that it is a meaningful way to present CRC’s results of operations for the year ended December 31, 2006.

Organization Change

Effective October 1, 2007, CRC realigned its operations and internal organization structure into three operating divisions: recovery division, youth division, and healthy living division. The recovery division provides substance abuse and behavioral disorder treatment services through residential treatment facilities and outpatient treatment clinics. The youth division provides educational programs for underachieving young people through residential schools and wilderness programs. The healthy living division provides adolescent and adult weight management programs and treatment services for eating disorders. For segment reporting purposes, we report in two segments: recovery and youth. The healthy living division is combined with corporate/other as it does not meet the quantitative threshold for separate segment reporting.

Historical Financial Results

Fourth Quarter and Year Ended December 31, 2007 Financial Results:

 

   

Consolidated net revenue for the fourth quarter of 2007 increased by $28.8 million, or 33.9%, to $113.9 million as compared to $85.1 million for the fourth quarter of 2006. Of the $28.8 million increase, the youth division contributed $18.7 million due to the Aspen acquisition in November 2006 and the remaining net revenue growth was driven by net revenue increases of $6.6 million, or 9.7%, and $3.5 million, or 177.4%, in the recovery division and corporate/other , respectively. In addition, same-facility revenue growth in the recovery division and corporate/other of $4.5 million, or 6.5%, and $0.5 million, or 59.4%, respectively, contributed to the net revenue growth. Our same-facility recovery division growth of $4.5 million was driven in part by a 4.7% increase in patient census and a 1.8% increase in revenue per patient day. The remaining net revenue growth in the recovery division was driven by start-up facilities and acquisitions in the third quarter of 2007. Our same-facility corporate/other growth was driven in part by a 56.2% increase in patient census and a 2.1% increase in revenue per patient day.

 

   

Consolidated net revenue for the year ended December 31, 2007 increased by $188.8 million, or 69.6%, to $460.0 million from $271.2 million for the same period in 2006. Of the $188.8 million increase, the youth division contributed $131.4 million and the remaining net revenue growth was driven by net revenue increases of $39.7 million, or 15.7%, and $17.8 million, or 364.2%, in recovery division and corporate/other, respectively. Of the $39.7 million and $17.8 million net revenue increases in the recovery division and corporate/other, respectively, $23.6 million and $16.5 million, respectively, was contributed by acquisitions and start-ups that were not fully included in both 2006 and 2007 results of operations. In addition, same-facility revenue growth in the recovery division and corporate/other of $16.0 million, or 6.4%, and $1.2 million, or 39.2%, respectively, contributed to the net revenue growth. Our same-facility recovery division growth was driven in part by a 5.4% increase in patient census and a 0.9% increase in revenue per patient day. Our same-facility corporate/other growth was driven in part by a 43.2% increase in patient census and a 2.8% decrease in revenue per patient day.

 

2


   

CRC’s consolidated operating margin was 8.7% for the fourth quarter of 2007, as compared to 15.0% for the fourth quarter of 2006. The decline in operating margin in 2007 was primarily attributable to lower operating margins associated with the Aspen acquisition and $2.2 million in non-recurring charges in the fourth quarter of 2007. On a same-facility basis, CRC’s consolidated operating margin decreased to 33.5% for the fourth quarter of 2007, as compared to 34.3% for the fourth quarter of 2006.

 

   

CRC’s consolidated operating margin was 14.5% for the year ended December 31, 2007, as compared to 3.5% for the year ended December 31, 2006. Non-recurring expenses of $43.7 million related to the Transactions incurred in 2006 resulted in lower operating margin for 2006. The 2007 operating margin was not impacted by such non-recurring expenses but was partially impacted by lower operating margins associated with the Aspen acquisition. On a same-facility basis, consolidated operating margin decreased to 36.7% in 2007 as compared to 37.1% in 2006.

 

   

Net income as a percentage of consolidated net revenue for the fourth quarter of 2007 was (5.3)% compared to 0.4% in the fourth quarter of 2006. The decrease in net income percentage in the fourth quarter of 2007 was primarily due to a decline in operating margin for the period as described above plus a non-recurring charge in the fourth quarter of 2007 related to the write-off of a potential acquisition of $1.3 million and non-cash charges for workers compensation based on an actuarial analysis and loss on fair value of our interest rate swap totaling $2.1 million. In addition, interest expense increase by $2.0 million in the fourth quarter of 2007 compared to the fourth quarter of 2006.

 

   

Net income as a percentage of consolidated net revenue for the year ended December 31, 2007 was 0.3% compared to (13.1)% in the year ended December 31, 2006. Net income increased by $36.9 million in 2007 compared to 2006. The increase in net income in 2007 was primarily attributable to the increase in operating income of $10.9 million driven by the Aspen acquisition, an increase in operating income of $8.3 million in our recovery division and a decrease in loss from operations of $38.2 million in the corporate/other division. The decrease in loss from operations in the corporate/other division was primarily due to a decrease in transaction related costs compared to 2006. Other income decreased by $1.9 million in 2007 due primarily to a loss on an interest rate swap agreement of $1.8 million. Income tax expense increased by $12.5 million in 2007 resulting in an expense of $3.1 million in 2007 compared to a $9.4 million benefit in 2006.

 

3


Pro Forma Financial Results

Adjusted pro forma EBITDA was $19.8 million for the three months ended December 31, 2007, compared to $22.4 million for the three months ended December 31, 2006, a decrease of $2.6 million, or 11.6%. The decrease of $2.6 million in adjusted pro forma EBITDA was due primarily to a 14.5% decline in census within the youth division residential business and in part to higher expenses relating to compliance with Sarbanes-Oxley 404 requirements and other professional fees. Adjusted pro forma EBITDA was $104.5 million for the year ended December 31, 2007, compared to $100.8 million for the year ended December 31, 2006, an increase of $3.7 million, or 3.7%.

In order to supplement its condensed consolidated financial statements presented in accordance with GAAP, CRC is providing a summary to show the computation of earnings before interest, taxes, depreciation and amortization (“EBITDA”), as well as adjusted pro forma EBITDA. Adjusted pro forma EBITDA takes into account certain adjustments which are excluded from EBITDA for purposes of various covenants in the indenture governing CRC’s 10 3/4% senior subordinated notes due 2016 and its senior secured credit facility, as amended to date. CRC believes that the adjusted pro forma EBITDA information presented provides useful information to both management and investors concerning its ability to meet its future debt obligations and to comply with certain covenants in its borrowing arrangements that are tied to these measures. CRC also believes that including the effect of these items allows management and investors to better compare CRC’s financial performance from period-to-period, and to better compare CRC’s financial performance with that of its competitors. The presentation of this additional information is not meant to be considered in isolation of, or as a substitute for, results prepared in accordance with GAAP.

The unaudited adjusted pro forma EBITDA for the periods presented gives effect to all acquisitions in 2006 and 2007 as if they had occurred on January 1, 2006. The pro forma adjustments are based upon available information and certain assumptions that CRC believes are reasonable. The pro forma adjusted EBITDA is for informational purposes only and does not purport to represent what CRC’s results of operations or financial position would have been if the acquisitions in 2006 and 2007 occurred at any date, nor does such information purport to project the results of operations for any future period.

 

4


CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 2007 AND DECEMBER 31, 2006

(In thousands, except share amounts)

 

     December 31,
2007
   December 31,
2006

ASSETS

     

CURRENT ASSETS:

     

Cash and cash equivalents

   $ 5,118    $ 4,206

Accounts receivable, net of allowance for doubtful accounts of $6,901 in 2007 and $8,235 in 2006

     31,910      33,805

Prepaid expenses

     7,544      7,675

Other current assets

     2,120      2,261

Income taxes receivable

     193      6,496

Deferred income taxes

     6,599      7,052
             

Total current assets

     53,484      61,495

PROPERTY AND EQUIPMENT—Net

     122,937      94,976

GOODWILL

     730,684      702,425

INTANGIBLE ASSETS—Net

     390,388      400,714

OTHER ASSETS

     24,798      29,178
             

TOTAL ASSETS

   $ 1,322,291    $ 1,288,788
             

LIABILITIES AND STOCKHOLDER’S EQUITY

     

CURRENT LIABILITIES:

     

Accounts payable

   $ 7,014    $ 6,714

Accrued liabilities

     37,582      34,827

Current portion of long-term debt

     35,603      10,743

Other current liabilities

     29,824      27,941
             

Total current liabilities

     110,023      80,225

LONG-TERM DEBT—Less current portion

     612,764      615,785

OTHER LONG-TERM LIABILITIES

     7,514      5,526

DEFERRED INCOME TAXES

     145,867      149,827
             

Total liabilities

     876,168      851,363
             

MINORITY INTEREST

     374      251

STOCKHOLDER’S EQUITY:

     

Common stock, $0.001 par value—1,000 shares authorized; 1,000 shares issued and outstanding at December 31, 2007 and December 31, 2006

     

Additional paid-in capital

     438,608      433,652

Retained earnings

     7,141      3,522
             

Total stockholder’s equity

     445,749      437,174
             

TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY

   $ 1,322,291    $ 1,288,788
             

 

5


CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands)

 

     Three
Months
Ended

Dec 31,
2007
    Three
Months
Ended

Dec 31,
2006
    Twelve
Months
Ended

Dec 31,
2007
    Twelve
Months
Ended

Dec 31,
2006
    Eleven
Months
Ended

Dec 31,
2006
    One
Month
Ended
Jan 31,

2006
 
     (Successor)     (Successor)     (Successor)     (Combined)     (Successor)     (Predecessor)  

NET REVENUE:

            

Net client service revenue

   $ 112,130     $ 83,809     $ 453,619     $ 266,240     $ 246,880     $ 19,360  

Other revenue

     1,784       1,285       6,387       4,938       4,448       490  
                                                

Net revenue

     113,914       85,094       460,006       271,178       251,328       19,850  
                                                

OPERATING EXPENSES:

            

Salaries and benefits

     59,435       41,692       226,566       128,219       118,954       9,265  

Supplies, facilities and other operating costs

     37,059       24,918       137,736       73,892       69,331       4,561  

Provision for doubtful accounts

     1,793       1,811       6,857       5,391       5,106       285  

Depreciation and amortization

     5,705       3,947       22,015       10,554       10,193       361  

Acquisition related costs

     —         —         —         43,710       —         43,710  
                                                

Total operating expenses

     103,992       72,368       393,174       261,766       203,584       58,182  
                                                

INCOME (LOSS) FROM OPERATIONS

     9,922       12,726       66,832       9,412       47,744       (38,332 )

INTEREST EXPENSE, NET

     (15,291 )     (13,240 )     (60,262 )     (43,843 )     (41,338 )     (2,505 )

OTHER FINANCING COSTS

     —         —         —         (10,655 )     —         (10,655 )

OTHER INCOME (EXPENSE )

     (974 )     124       (1,774 )     144       89       55  
                                                

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

     (6,343 )     (390 )     4,796       (44,942 )     6,495       (51,437 )

INCOME TAX EXPENSE (BENEFIT)

     (232 )     (683 )     3,143       (9,433 )     3,011       (12,444 )

MINORITY INTEREST IN INCOME (LOSS) OF A SUBSIDIARY

     (86 )     (38 )     189       (38 )     (38 )     —    
                                                

NET INCOME (LOSS)

   $ (6,025 )   $ 331     $ 1,464     $ (35,471 )   $ 3,522     $ (38,993 )
                                                

 

6


CRC HEALTH CORPORATION

Reconciliation of GAAP “Cash Flows (Used In) Provided By Operating Activities” to non-GAAP “EBITDA” from

continuing operations and Reconciliation of non-GAAP “EBITDA” from continuing operations to GAAP “Net Income”

(In thousands) (unaudited)

 

     Three
Months
Ended

Dec 31,
2007
    Three
Months
Ended

Dec 31,
2006
    Twelve
Months
Ended

Dec 31,
2007
    Twelve
Months
Ended

Dec 31,
2006
    Eleven
Months
Ended

Dec 31,
2006
    One
Month
Ended

Jan 31,
2006
 
     (Successor)     (Successor)     (Successor)     (Combined)     (Successor)     (Predecessor)  

Cash flows (used in) provided by operating activities

   $ 32,653     $ 1,897     $ 56,420     $ (3,285 )   $ (4,486 )   $ 1,201  

Write-off of debt discount and capitalized financing costs

     —         —         —         (10,655 )     —         (10,655 )

Amortization of debt discount and other financing costs

     (1,116 )     (924 )     (4,476 )     (3,068 )     (2,906 )     (162 )

Stock-based compensation

     (706 )     (883 )     (3,909 )     (21,135 )     (3,469 )     (17,666 )

Deferred income taxes

     (1,584 )     (306 )     (1,306 )     85       85       —    

Net effect of changes in non-current net assets

     345       230       (6,873 )     (1,060 )     271       (1,331 )

Net effect of working capital changes

     (29,912 )     4,264       (16,377 )     14,201       24,220       (10,019 )

Interest expense and other financing costs

     15,291       13,240       60,262       54,498       41,338       13,160  

Income tax expense (benefit)

     (232 )     (683 )     3,143       (9,433 )     3,011       (12,444 )
                                                

EBITDA from continuing operations

     14,739       16,835       86,884       20,148       58,064       (37,916 )
                                                

Interest expense and other financing costs

     (15,291 )     (13,240 )     (60,262 )     (54,498 )     (41,338 )     (13,160 )

Income tax expense (benefit)

     232       683       (3,143 )     9,433       (3,011 )     12,444  

Depreciation and amortization

     (5,705 )     (3,947 )     (22,015 )     (10,554 )     (10,193 )     (361 )
                                                

Net income (loss)

   $ (6,025 )   $ 331     $ 1,464     $ (35,471 )   $ 3,522     $ (38,993 )
                                                

 

7


CRC HEALTH CORPORATION

Reconciliation of non-GAAP “EBITDA from continuing operations” to non-GAAP “Adjusted pro forma EBITDA”

(In thousands) (unaudited)

 

     Three
Months
Ended
December 31,
2007
    Three
Months
Ended
December 31,
2006
    Twelve
Months
Ended
December 31,
2007
   Twelve
Months
Ended
December 31,
2006
 
     (Successor)     (Successor)     (Successor)    (Combined)  

EBITDA from continuing operations

   $ 14,739     $ 16,835     $ 86,884    $ 20,148  

Pre-acquisition Adjusted EBITDA from Aspen acquisition

       2,102       —        21,076  

Pre-acquisition Adjusted EBITDA from other acquisitions in 2006

     —         —         —        3,387  

Pre-acquisition Adjusted EBITDA from other acquisitions in 2007

       274       3,175      3,817  

Expenses incurred related to the Transactions

         4      43,710  

Unrecognized profit on deferred revenue

     53       1,901       2,748      3,456  

Stock-based compensation expense

     706       883       3,909      3,469  

Loss (gain) on interest rate swap

     1,027       (124 )     1,771      (164 )

(Gain) loss on fixed asset disposal

     228       (5 )     218      (42 )

Management fees to Bain

     668       508       2,201      1,834  

Profit in minority interest (no dividends paid)

     (86 )     (38 )     189      (38 )

Transaction expense

     58       (17 )     781      12  

Write-off of cancelled acquisitions

     1,267         1,298      22  

Franchise taxes

     74       101       176      163  

Write-off of miscellaneous accounts (non-cash)

     102         125   

Non cash charge for workers compensation actuarial analysis

     975       —         975      —    
                               

Adjusted Pro forma EBITDA

   $ 19,811     $ 22,420     $ 104,454    $ 100,850  
                               

 

8


CRC HEALTH CORPORATION

Selected Statistics

 

     Three
Months
Ended
December 31,
2007
    Three
Months
Ended
December 31,
2006
    Twelve
Months
Ended
December 31,
2007
    Twelve
Months
Ended
December 31,
2006
 
     (Successor)     (Successor)     (Successor)     (Combined)  

Recovery Division:

        

Number of inpatient facilities - end of period

     28       25       28       25  

Number of outpatient facilities - end of period

     15       14       15       14  

Number of comprehensive treatment clinics (CTC) - end of period

     62       59       62       59  

Available beds - end of period

     1,857       1,696       1,857       1,696  

Patient Days - Inpatient

     133,681       128,214       528,093       466,560  

Occupancy rate

     78.2 %     82.2 %     82.1 %     86.1 %

Net revenue per patient day - inpatient

   $ 364.99     $ 343.46     $ 356.64     $ 345.69  

Patient Days - CTC

     2,359,588       2,221,835       9,223,803       8,295,023  

Net revenue per patient day - CTC

   $ 11.26     $ 11.14     $ 11.20     $ 11.12  

Youth Division:

        

Number of facilities - end of period

     29       26       29       26  

Patient days

     116,437       88,560       524,124       88,560  

Net revenue per patient day

   $ 284.88     $ 183.51     $ 283.29     $ 183.51  

Healthy Living Division:

        

Number of facilities - end of period

     13       10       13       10  

Patient days

     17,077       6,637       80,896       9,464  

Net revenue per patient day

   $ 313.46     $ 272.97     $ 274.39     $ 456.69  

 

9


Conference Call

CRC will host a conference call, open to all interested parties, on Wednesday, April 9, 2008 beginning at 10:00 AM Pacific Daylight Time (1:00 PM Eastern Daylight Time). The number to call within the United States is (888) 278-8466. Participants outside the United States should call (913)-312-1480. The conference ID is 4531381. A replay of the conference call will be available starting at 4:00 PM Pacific Daylight Time on Wednesday, April 9, 2008 until 10:00 PM Pacific Daylight Time on Wednesday, April 16, 2008. The replay number for callers within the United States is (888)-203-1112 or (719)-457-0820 from outside the United States and the conference ID for all callers is 4531381.

Forward-Looking Statements

This press release includes or may include “forward-looking statements.” All statements included herein, other than statements of historical fact, may constitute forward-looking statements. Although CRC believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, among others, the following factors: changes in government reimbursement for CRC’s services; our substantial indebtedness; changes in applicable regulations or a government investigation or assertion that CRC has violated applicable regulations; attempts by local residents to force our closure or relocation; the potentially difficult, unsuccessful or costly integration of recently acquired operations and future acquisitions; the potentially difficult, unsuccessful or costly opening and operating of new treatment facilities; the possibility that commercial payors for CRC’s services may undertake future cost containment initiatives; the limited number of national suppliers of methadone used in CRC’s outpatient treatment clinics; the failure to maintain established relationships or cultivate new relationships with patient referral sources; shortages in qualified healthcare workers; natural disasters such as hurricanes, earthquakes and floods; competition that limits CRC’s ability to grow; the potentially costly implementation of new information systems to comply with federal and state initiatives relating to patient privacy, security of medical information and electronic transactions; the potentially costly implementation of accounting and other management systems and resources in response to financial reporting and other requirements; the loss of key members of CRC’s management; claims asserted against CRC or lack of adequate available insurance; and certain restrictive covenants in CRC’s debt documents.

 

10

GRAPHIC 3 g39920001.jpg GRAPHIC begin 644 g39920001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!X17AI9@``24DJ``@````&`#$!`@`1 M````5@````$#!0`!````:`````,#`0`!`````@EO!1!1`0`!`````0```!%1 M!``!````Q`X``!)1!``!````Q`X```````!-:6-R;W-O9G0@3V9F:6-E`/6@ MA@$`C[$``/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H< M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T- M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R M,C(R,C(R,C(R,O_``!$(`&\!&@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0`` M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$% M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U M-CH.$A8:'B(F* MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G: MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(# M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q M$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8 MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?J@N[RVL+22ZNYXX((QN>21L!1 M3KFYAL[66YN)%CAB4N[L>%`Y)KYJ\<^.+SQ=J;!7>/3(F_T>#IG_`&V]2?TK M>A0=5^1A7KJDO,[?Q/\`&HB1[;PY;J5''VNX7K_NI_4_E7G5[XU\3:A(7N-< MON3G$O3H4X+1'DU,14F]6:?_``D>N_\`0;U+_P`"Y/\`&C_A M(]=_Z#>I?^!1ZBC(]16G+'L9\\NYIMXBUQE*MK6I$'J#=R?XU'_;6K M?]!2^_\``A_\:H9'J*,CU%'*NPN:7:\L)&.HKTKXN?ZSPU_V#1_2L9I>TA\S>G)^SG\C MA/[:U;_H*7W_`($/_C1_;6K?]!2^_P#`A_\`&J-*JLQPJECZ`9K;E78PYI=R M[_;6K?\`04OO_`A_\:/[:U;_`*"E]_X$/_C53R9O^>,G_?!H\F;_`)XR?]\& MBT1WD7XO$.MP-NBUC4$/M=T@U^R^S$\?:+?+)^*GD?AFO5+*] MM=1M([JSGCGMY!E)(VR"*^0*Z[P%XQG\,ZLL$TSG2KH^7<1AC\F>-Z^A%<5? M!1:YJ>YV4,;*_+,]K\4_$70O"Q:":4W5\!_Q[0M/ECV#GEW-3_A(]=_Z#>I?^!7$[;Q;XNU86EIK6II"F#/<&ZDVQ+^? M)]!63X6\+W_BS5ELK%<(,&:=A\L2^I]_0=Z^EO#OAZP\,Z1%IUA'A%Y=S]Z1 MN[$^MA9TK3H]*TV&RCEGF$8P9)Y"[N>Y)-7***\EN M[NSUDK:(****0PHHHH`*6DI:`/)_C5XB>UTZUT&!\-=_O9\'_EF#P/Q/_H-> M(5UOQ,U)M2\?:FQ.4MV%NGL%&#^N:Y*O'B9\]1L`"2``23T`KVWP M-\);2.RCU'Q)#YUQ*`R6C$A8AVW8ZM[=!7(?"3PXFM^*_M=P@>VTY1*01PTA M^X/YG\*^B*YL9B'%\D3IP>'4ESR,N+PUH4,8CCT>P51T`MT_PI__``C^C?\` M0)L?_`=/\*T:*\[FEW/1Y8]C._X1_1O^@38_^`Z?X4?\(_HW_0)L?_`=/\*T M:*.9]PY8]C._X1_1O^@38_\`@.G^%>/?'%536](50`HM6``'`&ZOI6_AR]#RJ/\`$CZGTEY,7_/-/^^11Y,7_/-/^^13Z*\`]\AE ML[:9"DMO#(IZJZ`BN'\4_"K0]9M9)=-MTT^_`)1H1B-SZ,O3'N*[ZBKA4E!W MBR)TXS5I(^/KFVFL[J:UN(S'-"YCD0]58'!%1=:Z3X@7%O=>/=8EM2#$9]N5 MZ%@`&/Y@US=>_!\T4V>#-!R6EOYF1?4W>#-`3 MPUX5LM/"@3!/,G/]Z1N6_P`/PKBJ5O94[1WN_P`SMIT?:U+RVLOR(=-\`>%] M+@6.'1K:0@8,DZ"1C]2W]*O_`/"+>'_^@)IW_@,G^%:U%>:ZDWJV>BJ<5HD9 M/_"+>'_^@)IW_@,G^%'_``BWA_\`Z`FG?^`R?X5K44N>7'_\` MH":=_P"`R?X4?\(MX?\`^@)IW_@,G^%:U%'/+N')'L5K+3K+38VCL;2"V1CE MEAC"`GU.*LT45+=RDK!1110`4444`%%%%`!2TE+0!\B:O<&ZUJ_N" MF5YY\&)`_@38#REW*#^.#_6O0Z\+$?Q9'N8=6I1L%%%%8FP4444`%>'?'/\` MY#ND_P#7L_\`Z%7N->'?'/\`Y#ND_P#7L_\`Z%75@_XR.7&?P6>55UWPRGBM M_B!ITL\L<4:B3+R,%`^0]S7(T$9ZU[$X\T7'N>1"7+)2['UT-6TX@$:A:D'H M1,O^--DUK2HAF34[-._S3J/ZU\C8%&T'J!7!_9Z_F.[^T'_*?4E[X^\*V`/G M:Y:$C^&-_,/Y+FO./&?QA^V6LEAX<66)9!M>\D&UL>B#M]37D=%:T\%3B[O4 MRJ8VI)66@=3DT^*&2XFCAA0O+(P1%'4L3@"F5WOAC3X?"6FCQ?K<7[[!&E6; M\-+)C_6$=E'_`-?TKIG/E7F<].',_(V]5@B/C+P;X-1@\6EB,W&.AD.&;]!^ MM>W5\T^`[^6[^)^G7MX_FSW%P[.[=V93S7TM7E8N+BXQ\CU<)+F4I>84445Q MG6%%%%`!1110`4444`%%%%`!1110`4444`%+24M`'RKXTLCI_C76;?&`+IW7 MZ,=P_G6%7J'QLT4VOB"TU=%_=WD7EN?]M/\`%2/RKR^O?H3YZ:9X->')4:/: M/@9J*FSU;3"WSI(LZCU!&T_J!^=>O5\M^"/$A\+>*+;4&R;9OW5PH[QGJ?P. M#^%?3]MS_^A5[C7AWQS_Y#ND_]>S_^A5U8/^,CEQG\%GE5=#X' MT:T\0>++72[T/Y$ZR`E&P00A((^A%<]78_"S_DHNF?23_P!`:O6JMJ#:['DT MDG4BGW*?C#P5J7@^^\NY4S6//AM=^%Y'OK$/VAQ* MU]3U6[\%:=\.-&37=7@_MJ^\T1Q0CY;>-R"06SRW3_ZU>=:YKNH>(M2>_P!2 MG\R4C"J.%1>RJ.PKT32_&$7COPU+X3\07*6^H2!?LE\X^61P^?7KY MQK.C7^@:E)I^I0-#.GKT8>JGN*YJ%^9^T^+]/(Z:]N5>S^']?,-#OSI6O:?? M@X^SW"2'Z`\_IFOK5'61%=&#*PR".XKX[ZU]%_"[Q7;Z[X9M["28?VC91B.2 M-CRR#A6'J,8'UK''TVTIKH;X"HDW!G=T445Y9Z84444`%%%%`!1110`4444` M%%%%`!1110`4M)2T`<]XT\-IXI\,W.G<"?'F6[G^&0=/P/3\:^79X)K6XDM[ MB-HYHF*.C#!5AU!K["KS?XC?#8>(]VJZ2$CU15_>1GA;@#W[-[]Z[<)B%!\D MMF<6+P[J+FCN>`UTOAKQYKWA5?*L;E9+7.3;3CJ/+C*4'=:,]4'QSU8`9T:R)]1(PI?\`A>>J_P#0 M&L_^_K5Y516/U6C_`"FOUJMW/5?^%YZK_P!`:S_[^M1_PO/5?^@-9_\`?UJ\ MJHH^JT?Y0^M5NYZK_P`+SU7/_(&L_P#OZU1?&J4SZGHS+$#ME@:\O'4 M?6O3?C)_Q^>'_P#KP_J*CV4*=6/*K;FGM9U*4N9]CS*NQ^%G_)1=,^DG_H#5 MQU=C\+/^2BZ9])/_`$!JVK?PY>C,*/\`$CZGTK371)8VCD171AAE89!'H13J M*\`]\\2\?_"E[/S=6\.Q%[?[TUDO+1^I3U'MV[5Y-7V-7F'C_P"%L.L"75=" M1(=0Y:6`<)/[CT;]#7HX;&?9J?>>=B<'?WJ?W'A%=]HWB;3O$FFQ^'?&#G"_ M+9:K_P`M(#V#GNOU_'U'"SP2VT\D%Q$\4T;%7C<893Z$5'7H3@IHX(3<&;/B M3PSJ'A?4?LM\@*-\T-PG,7-A=1W5G/)!<1G*21MAA^-==X;\7 MVK:LEH>S*>N!Z?_JK.\5>$+KPU-',DBWFE7'S6M[%RC@] M`?1JB,W?DGO^94H*W/#;\CIM.^-7B&T@$=W:V=ZP&!(P*,?KCC]*N?\`"\]5 M_P"@-9_]_6KRJBI>&I/[)2Q55?:/5?\`A>>J_P#0&L_^_K4?\+SU7_H#6?\` MW]:O*J*/JM'^4/K5;N>J_P#"\]5_Z`UG_P!_6H_X7GJO_0&L_P#OZU>544?5 M:/\`*'UJMW/5?^%YZK_T!K/_`+^M1_PO/5?^@-9_]_6KRJBCZK1_E#ZU6[GJ MO_"\]5_Z`UG_`-_6H_X7GJO_`$!K/_OZU>544?5:/\H?6JW<]5_X7GJO_0&L M_P#OZU'_``O/5?\`H#6?_?UJ\JHH^JT?Y0^M5NYZK_PO/5?^@-9_]_6KT/P/ MX\LO&-FRE5M]1B&9;;=GC^\OJ/Y5\SU9T_4+O2K^&^L9VAN86W(Z]O\`$>U9 MU,'3E&T59FE/&5(R]YW1]>TM M3.#@^61ZT9*:YHB4445)1DZUX9T;Q#$(]4T^&XP/E,HO$FL:OI\=G)`VFR!&=G!#\L,@=ON_K6U.I5 MBFX/1&-2G2DTIK5G&_\`"BK#_H.77_?E?\:/^%%6'_0S^%19R"6*(2FXWC:?E#8Q^-73VDK1LT3YS@XS@#BM MU4Q,M$_/H8NGAENOS,__`(458?\`03-]X8.,]!UK&U7XB:=I7C2U\.2PNSRE%DN`X"Q,WW01 M^7YU*K8AMQ3U7H-T<.DI-:,Y?_A1=A_T'+K_`+\K_C71>+?AQ;>+)K&2;49K M?[)!Y("1AMP]>:Z[4;P:?IEW>LA<6\+RE0<%MJDX_2L3P[XNC\0^$Y==BLI( MUC$F("P9FV#.`0.]1[:M+W[[?J7[&C'W+;G%?\**L/\`H.77_?E?\:UO#/PH MM/#6OVVK1:K/.\&[$;1*`<@CK^-9O_"Z5\\0'PQ?B1+X MAT/1WTV9)=5MDN`S.!Y6X$[2,>\E& M8K:+[Q'J?05R]O\`&..&XC76?#U]I]O*?EF.6X]<%1G\*N-"I)+GCGGWVMXG'VB$#+=/-UITC!D.)89!AXS[C^M<9-\98HKJZAC\.WDRVTC1N\< M@(&"1D\<=*?-B*EX]@YF_\`"BK# M_H.77_?E?\:ZJT^(6F:AX.O?$-G%)(+)QKG(?C79YADNM!OH M+60X\\,&'U'`S^=6IXIWMT]"'#"K?KZD'_"BK#_H.77_`'Y7_&C_`(458?\` M0WH$J>&BDVM_4C_`.%%6'_0I:>[&)B596&&1AU4CUK#UGXB:=HOC"T\/30N[S;!).'` M6$L?E!'Y?G4JMB&W%/5#='#I*36AR_\`PHJP_P"@Y=?]^5_QH_X458?]!RZ_ M[\K_`(UVGC#Q:?"=O:S#2[B_$[,I$)QL`&&_BDGB358K.+0KN*-PY- MP7W(NU"V"0.^,?C5*IB7'F3T^0G3PRERM:_,R/\`A15A_P!!RZ_[\K_C1_PH MJP_Z#EU_WY7_`!KM/!WC"'Q?IEU?1VCVB6\QA82.&S@`YS^-F`21[\4*IB7)Q3U7H#IX914FM_4S_P#A15A_T'+K_ORO M^-'_``HJP_Z#EU_WY7_&NE\)_$C3?$UZVG36\NG:D,XMYS]['7!XY]B`:9XE M^)-EX7\30:1=V4K)(J.]PKC"*Q(SCOC%'M,3SG(&"*&(+8Y(&,FL#Q7XHA\+>'_[7:W:ZCWH@ M6-P,[NAS6OIUX-0TRTO50H+B%)0I.2NY0!O"VJ:%XD\1WM] M'&L%],'@*R!B1N<\CM]X5T49J,97.>M!RE&QR/@^[U6^^,\]QK=HMIJ#6A\R M%1@*`B@=SVP:H:?JVOZ3\1O%$GA_21J4LD[+*A!.Q=QP>"*[ZW\+ZI'\7KKQ M$T$9-7\160T^>%)))8>FU5SCKZ@5\^W%_INKZ?K M6JZA>,FO3W:S6L81B-N>1D<#@C'^[7K6NZ1XYUSP!'I5REL^ISW!^U,LBHHB M!RHXX.>/RKH-+^'_`(=LM)M;2?2;2XECB"23/&"SMCDY^N:BG4A2O)[M]"ZE M.=5I+9+J5-.UX>)/A5=:@6!F.GS1SCTD5"#^?7\:J?!O_DGT/_7Q+_,51\,> M#=>\/VWB?2#'&^F7L,OV)_-&=Y!5>32<8.,HQDM[C4IJ492B]K&C/_`,G"VW_7G_[3:L[XB7&HVGQ7T6?2 M;9;F_2U!AA8<.7'_`&>MMY;/Y@W;MA'W?J:76_"^ MJ7WQ1T778(XS86D6V5C(`P/S]!WZBB-2*DG?[(I0DXM?WCSCQGJWBO4KO1%\ M2:1'8(EUF$H,;R2N>Y]J^@:X7XC^%]4\2/HATV.-Q:7!DEWR!<#Y>F>O0UW5 M95IJ4(VTW-:,'&@6\&K_&_79=3VR368/V6.09`QM`('L#G\`[^^UN+Q)X:NUM-8B`#ACA9<#`Y]<<<\$ M5CSZ;\5/$2K8WTUOI-MD>9/#(H9L?[C$_AQ5R2J6DI)67W$1;IWBXMW9!\4[ M&TLG\+Z%!&MGH\ERQD2,85?F4']&;\Z]9MK6WL[2.UMH4B@C4(D:C``]*Y;6 M_`-IK/@^'0Y;N=Y[8;X;R=B[^9W+9Z@YZ?X5RL%K\6M*M5TJW%G=0H-D=XTB M$JO;[Q!/X@FAVJ045+:^_P"8U>G-R<=[;?D-TB"'1_CS=V6EX2UN+=FGB3[J ML4#$8[?-@^V:YCPSX[B\%ZIXA$NG2W?VJ[;:5<*%*LW!R/>O3/`G@23PU)KQ11&^N?/LI5<,48%B# MQTZ@$>AK55*3NI.ZLEZF3IU$DXZ.[?H9&F:!J.G?#CQ?JVHVWV1M23?';8QM M7<3G';[W'L*RK/5O$>L_#^U\*:?X:EFMW&T7FTD,-Y;()&!SQG/K7>V6A^+) M_AOJ/AW58(GNQ#Y5I*)PWF+G@,>V,=?3%=-X)TF[T/P=INFWRJMS`C!PK;@" M6)Z_0TI5E%-NS=_T'&BVTE=*WZGE^O:-]F\2^!?"^JR;K*&!1*,_([ECN'T) M`7Z&O:Q!$(/($2"';L\O:-NWIC'I7,>.O!47C#3HA',+;4+9BUO/V![@XYQP M/I7)"'XNK;?V6/LA3&S[?YD>['3.2WD[M&=X M"$E0NTC'/3]:]6\&>!4\*:1=B2876IWBGSY^V<'"C/.,D\GK7):;\+=0E\!W MVFZA'##JBWC7-E(L@;'RJ,$CH#C'Y&ME5I-OFU6G_#F+IU4ER[Z_\,;GPWT> MY\'>"[Z]UE3;&1VNGA;@Q(%[^AXZ?2O(;K4=,UNTU_5=2NVCUNXN$ELXPC$! M0>1D<#@@<_W:]6U72?'&K_#M-#GM8/[0,BQS3?:%Q)".03[D@`_3/>N@TCX? M>'[#1K2TN=*M+B>.(++,\8+.V.3GZU,:T8-SD[MOIY#E2E-*$59)=2+PYKX\ M1_#=KYFS<+:213^TBJ0?SX/XUA?!_P#Y)W>?]?$O_H"U)X2\'ZYX:NO$6G>7 M&^D7B.;5_-&0V"%R.V0<'Z5I_#OPUJ7ASP?"9IH/#$T&HZ9(Y9(9F4%/J&(P?H>?2KJ2C4YHIVUOZD4XRI\LFKZ6 M]`^,,$%AJ.@ZQ9@1ZI]HVADX9PN",^N#Q^-5?&FCP>(/C%::7)(/$/C2ZCDDMR#!9QD$*1R,XX`!YP,Y[FM6_P#"^J7' MQ:T_Q#''&=.AM_+=S(-P.''3\13C4C"T4]4GJ$JV>&O\`D5='_P"O*'_T`5PGQ,^'5WXDO;?4 M]&CB-X5\NX1W"!U'W6SZCI^7I7H.BVLMEH6G6DX`E@MHXW`.0&50#^HK.M.$ - -J:<>YI1A*-1\W8__V3\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----